The results suggested that plasma MTBR-tau243 could help estimate the tauopathy load in Alzheimer's disease, improving ...

A LANDMARK genome-wide association study of 1,483 Lewy body disease (LBD) cases has identified APOE ε4 as the strongest ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial of neflamapimod in dementia with Lewy bodies (DLB), ...

In DLB, the nerve cells that are affected are in areas of the brain that control our thinking, memory, and body movement. Is dementia with Lewy bodies related to Parkinson's disease and Parkinson's ...

Lewy body dementia (LBD) is a progressive condition. The average life expectancy is around 5 to 8 years following a diagnosis, but it can be up to 20 years. There is no cure for LBD, but treatment ...

The disorder is also associated with a very high risk of Parkinson's disease and a related condition called Dementia with Lewy Bodies. This is a form of dementia that often causes memory and ...

The disorder is also associated with a very high risk of Parkinson's disease and a related condition called Dementia with Lewy Bodies. This is a form of dementia that often causes memory and ...

“As presented at the recent International Lewy Body Dementia Conference ... study for evidence of Alzheimer’s disease related co-pathology, were more pronounced. On CGIC, which was ...